CDX-6311

N/A

Report date: 2024/09/10 14:57:17

Base Information

Drug NameCDX-6311
Drug Alias NameCDX6311
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of Actionα-Galactosidase replacementsGene transference
Targetsα-Galactosidase
Therapy Area/IndicationsFabry Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCodexis Inc
China Registration ClassN/A

Develop Information

Active CompaniesCrosswalk Therapeutics IncCodexis IncTakeda Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsFabry Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A